drugset / Trial / NCT00183612

Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents

NCT00183612

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will examine the safety and effectiveness of the antipsychotic drug olanzapine in children and adolescents with bipolar disorder or psychosis.

Timeline

Start
2000-05
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule